General Information of This Metabolic Reaction (MR) (ID:
MR001000) |
Formula |
Reactant |
Exemestane |
Product |
6-hydroxymethylandrosta-1,4,6-triene-3,17-dione |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Cytochrome P450 3A (CYP3A)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Deamination
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17beta-dihydroexemestane. Pharmacol Res Perspect. 2017 Apr 27;5(3):e00314.
|
2 |
LABEL:EXEMESTANE tablet
|
3 |
Inhibition of the aromatase enzyme by exemestane cysteine conjugates. Mol Pharmacol. 2022 Aug 11;102(5):216-22. doi: 10.1124/molpharm.122.000545.
|
4 |
Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane. J Pharmacol Exp Ther. 2022 Sep;382(3):327-334. doi: 10.1124/jpet.122.001232.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.